Clinical Trial Update: Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of chemoembolization and radiofrequency ablation for hepatocellular carcinoma larger than 3 cm; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shandong University | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED